The Recall Desk
HighFDA (Devices)·Z-1632-2024·Announced 2024-05-01

Hip replacement acetabular shells recalled for deburring defect

Howmedica is recalling hip replacement acetabular shells that may have excessive deburring, resulting in a smooth surface on the shell edge. The recall affects devices distributed nationwide and internationally.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is an FDA Class II device recall with no reported illnesses or injuries. The hazard—excessive deburring causing a smooth surface on the acetabular shell edge—is a manufacturing defect in a high-risk implant device, meeting the rubric criterion for score 3: risk-of-harm products where injury has not yet been reported.

Plain-English summary

Howmedica Osteonics Corp. is recalling TRIDENTII PSL CLUSTER64H hip replacement acetabular shells (Catalog Number 742-11-64H, Lot Number 15611151). The acetabular shell may have excessive deburring, resulting in a smooth surface on the edge of the shell. The product is indicated for use in primary and revision hip replacement patients at high risk of hip dislocation.

The recalled shells were distributed nationwide and to the Netherlands, Canada, Singapore, Spain, Sweden, and the UK. The U.S. Food and Drug Administration classified this as a Class II recall.

The recalled product

Product
TRIDENTII PSL CLUSTER64H- Indicated for use in primary and revision patients at high risk of hip dislocation Catalog Number: 742-11-64H
Manufacturer
Howmedica Osteonics Corp.
Hazard
  • manufacturing-defect
  • edge-finish-defect

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • UDI-DI: (01)07613327380927(17)290313(10) Lot Number: 15611151

Distribution

Distributed nationwide across the United States.